Clinical studies are ongoing evaluating the PSMA protein as a molecular target for prostate cancer.Clinical trial information: NCT04740034.Gerald Steven FalchookSarah Cannon Research Institute at HealthONE, Denver, COMeredith McKeanSarah Cannon Research Institute, Nashville, TNWilliam Kevin Kelly...
[1]. Block GA, et al. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial. JAMA. 2017 Jan 10;317(2):156-164. 其他产品列表: ...
Etelcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces PTH levels in subtotal nephrectomized (Nx) rats and in hemodialysis patients with secondary hyperparathyroidism (SHPT) in clinical studies; however, effects of etelcalcetide on bone have not been determined....
[2]转移性前列腺癌化疗中国专家共识.中华泌尿外科杂志 2017,38(3):161-165. [3]Virgo KS, et al. Second-Line Hormonal Therapy for Men With Chemotherapy-Nave, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion. J Clin Oncol. 2017;35(17):1952-196...
Trial InformationBone & Cancer Foundation
In this multicentre, randomised, double-blind, placebo-controlled, phase 2 trial, patients aged 18–60 years with 4 to 14 migraine days per month were enrolled at 59 headache and clinical research centres in North America and Europe, and randomly assigned in a 3:2:2:2 ratio to monthly ...